ArticleThe ultrasound journal2026
Modified lung ultrasound score and related findings in children with Mycoplasma pneumoniae pneumonia.
Article in The ultrasound journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and validation of a nomogram for stratifying severeFrontiers in pediatrics · 2026Article
- Lung ultrasound radiomics for identifying severeFrontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDifferent pathogens cause pneumonia with overlapping symptoms, labs, and imaging, complicating early diagnosis. The modified lung ultrasound score (MLUS) shows value in lung disease evaluation, but its ability to differentiate pathogens is unclear. This study assessed MLUS for early identification of mycoplasma, viral, and bacterial pneumonia in children.
methodsWe enrolled 186 children with suspected pneumonia (Jan-Dec 2023). Clinical data, labs, lung ultrasound findings (A-lines, B-lines, solid lesions, pleural effusion), and pathogens were recorded. MLUS was assigned. Based on pathogens, cases were grouped into mycoplasma (n=74), viral (n=63), and bacterial (n=49) pneumonia for comparison.
results1. The median age of the mycoplasma pneumonia group was 6 (4.58,8) years, greater than that of the bacterial pneumonia group (3 [1.1,4.83] years) and the viral pneumonia group (3.41 [1.16,4.75] years) (P＜ 0.05). The mycoplasma pneumonia group had more febrile symptoms, extensive solid lung lesions, and fewer asthmatic symptoms than the other two pathogen groups (P < 0.05). 2. The median MLUS for mycoplasma pneumonia group was 15 (10,22), significantly higher than the median score of 9 (5,16) in the bacterial pneumonia group and 8 (5,15) in the viral pneumonia group (P < 0.05). 3. Coughing up sputum and small lung solid changes were significantly more common in the mycoplasma pneumonia group than in the bacterial pneumonia group (P < 0.05).
conclusionsA high modified lung ultrasound score, extensive solid lung lesions, older age, fever, and fewer shortness-of-breath symptoms strongly suggest mycoplasma pneumoniae infection. These findings provide critical evidence for early, targeted clinical management.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.